Drugs / Yiqi Gubiao pill
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT06676800 | Nov 2024 → Feb 2025 overdue | pulmonary tuberculosis | Fourth Affiliated Hospital of Xinjiang Medical University | Not yet recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Yiqi Gubiao pill | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06676800 ↗ |
| Known as | Yiqi Gubiao Wan | “Preliminary studies have shown that Yiqi Gubiao Wan has significant effects in relieving cough, alleviating asthma, expectorating phlegm, and delaying airway obstruction.” NCT06676800 ↗ |
| Route | Oral | “Take 10 pills orally each time” NCT06676800 ↗ |